The effect of cobra venom factor on alternative pathway hemolytic activity in mice

Keith A Joiner, A. Hawiger, J. A. Celfand

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The in vivo effect of cobra venom factor (CVF) on murine alternative complement pathway hemolytic activity was measured with a recently developed microassay. Four different dosage schedules of CVF were compared. Hemolytic titers were lowered to less than 5% of the baseline value by 6 hours after the first dose of CVF (62.5 - 200 U/kg), and remained low for 3-5 days, depending upon total dose, route and schedule of CVF administration. Titers at days 6-9 after initial CVF injection increased above baseline in animals given two doses of CVF separated by 48 hours.

Original languageEnglish (US)
Pages (from-to)277-281
Number of pages5
JournalImmunological Investigations
Volume9
Issue number3
DOIs
StatePublished - 1980
Externally publishedYes

Fingerprint

Appointments and Schedules
Alternative Complement Pathway
cobra venom factor
Injections

ASJC Scopus subject areas

  • Immunology

Cite this

The effect of cobra venom factor on alternative pathway hemolytic activity in mice. / Joiner, Keith A; Hawiger, A.; Celfand, J. A.

In: Immunological Investigations, Vol. 9, No. 3, 1980, p. 277-281.

Research output: Contribution to journalArticle

@article{412a742ab13841a293dd1cde7c709856,
title = "The effect of cobra venom factor on alternative pathway hemolytic activity in mice",
abstract = "The in vivo effect of cobra venom factor (CVF) on murine alternative complement pathway hemolytic activity was measured with a recently developed microassay. Four different dosage schedules of CVF were compared. Hemolytic titers were lowered to less than 5{\%} of the baseline value by 6 hours after the first dose of CVF (62.5 - 200 U/kg), and remained low for 3-5 days, depending upon total dose, route and schedule of CVF administration. Titers at days 6-9 after initial CVF injection increased above baseline in animals given two doses of CVF separated by 48 hours.",
author = "Joiner, {Keith A} and A. Hawiger and Celfand, {J. A.}",
year = "1980",
doi = "10.3109/08820138009066000",
language = "English (US)",
volume = "9",
pages = "277--281",
journal = "Immunological Investigations",
issn = "0882-0139",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - The effect of cobra venom factor on alternative pathway hemolytic activity in mice

AU - Joiner, Keith A

AU - Hawiger, A.

AU - Celfand, J. A.

PY - 1980

Y1 - 1980

N2 - The in vivo effect of cobra venom factor (CVF) on murine alternative complement pathway hemolytic activity was measured with a recently developed microassay. Four different dosage schedules of CVF were compared. Hemolytic titers were lowered to less than 5% of the baseline value by 6 hours after the first dose of CVF (62.5 - 200 U/kg), and remained low for 3-5 days, depending upon total dose, route and schedule of CVF administration. Titers at days 6-9 after initial CVF injection increased above baseline in animals given two doses of CVF separated by 48 hours.

AB - The in vivo effect of cobra venom factor (CVF) on murine alternative complement pathway hemolytic activity was measured with a recently developed microassay. Four different dosage schedules of CVF were compared. Hemolytic titers were lowered to less than 5% of the baseline value by 6 hours after the first dose of CVF (62.5 - 200 U/kg), and remained low for 3-5 days, depending upon total dose, route and schedule of CVF administration. Titers at days 6-9 after initial CVF injection increased above baseline in animals given two doses of CVF separated by 48 hours.

UR - http://www.scopus.com/inward/record.url?scp=84907109195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907109195&partnerID=8YFLogxK

U2 - 10.3109/08820138009066000

DO - 10.3109/08820138009066000

M3 - Article

C2 - 7399569

AN - SCOPUS:84907109195

VL - 9

SP - 277

EP - 281

JO - Immunological Investigations

JF - Immunological Investigations

SN - 0882-0139

IS - 3

ER -